New Breath Biomarker Panel Test Can Distinguish Chronic Lung Diseases

New Breath Biomarker Panel Test Can Distinguish Chronic Lung Diseases

283766

New Breath Biomarker Panel Test Can Distinguish Chronic Lung Diseases

Owlstone Medical has launched a new breath biomarker panel test — a “breathalyzer for disease” — to distinguish different chronic inflammatory lung diseases, including idiopathic pulmonary fibrosis (IPF), asthma, and chronic obstructive pulmonary disease (COPD). The new panel test was designed to support research seeking ways to distinguish the various types of chronic lung diseases. Besides supporting research, the company’s new test, called the Respiratory Diseases Research Use Only (RUO) Panel, also aims to improve…

You must be logged in to read/download the full post.